A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism

New England Journal of Medicine

Volumn 337, Issue 10, 1997, Pages 663-669

  Simonneau, Gérald ^a   Sors, Hervé ^b   Charbonnier, Bernard ^c   Page, Yves ^d   Laaban, Jean Pierre ^e   Azarian, Réza ^f   Laurent, Marcel ^g   Hirsch, Jean Lou ^h   Ferrari, Emile ⁱ   Bosson, Jean Luc ^j   Mottier, Dominique ^k   Beau, Bertrand ^l  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b Hopital Laennec   (France)

^c SERVICE DE DERMATOLOGIE   (France)

^d SERVICE DE NEUROLOGIE   (France)

^e HÔTEL DIEU   (France)

^f CENTRE HOSPITALIER DE VERSAILLES   (France)

^g Hotel Dieu CHU Rennes   (France)

^h CENTRE HOSPITALIER D AVIGNON   (France)

ⁱ PASTEUR HOSPITAL   (France)

^j GRENOBLE UNIVERSITY HOSPITAL   (France)

^k SERVICE DE RHUMATOLOGIE   (France)

^l Leo Pharmaceuticals   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN;

ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 8544273238     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199709043371002     Document Type: Article

References (18)

1. Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992;79: 1-17.
2. Ginsberg JS. Management of venous thromboembolism. N Engl J Med 1996;335:1816-28.
3. Leizorovicz A, Simonneau G, Decousus H, Boissel JP. Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis. BMJ 1994;309:299-304.
4. Lensing AWA, Prins MH, Davidson BL, Hirsh J. Treatment of deep venous thrombosis with low-molecular-weight heparins: a meta-analysis. Arch Intern Med 1995;155:601-7.
5. Siragusa S, Cosmi B, Piovella F, Hirsh J, Ginsberg JS. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am J Med 1996;100:269-77.
6. Théry C, Simonneau G, Meyer G, et al. Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism: a dose-ranging study. Circulation 1992;85:1380-9.
7. Meyer G, Brenot F, Pacouret G, et al. Subcutaneous low-molecular-weight heparin Fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study. Thromb Haemost 1995;74:1432-5.
8. Hull RD, Raskob GE, Pineo GF, et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 1992;326:975-82.
9. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA 1990;263:2753-9.
10. Meyer G, Collignon MA, Guinet F, Jeffrey AA, Barritault L, Sors H. Comparison of perfusion lung scanning and angiography in the estimation of vascular obstruction in acute pulmonary embolism. Eur J Nucl Med 1990;17:315-9.
11. Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet 1960;1:1309-12.
12. Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest 1995;108:Suppl:335S-351S.
13. The Urokinase Pulmonary Embolism Trial: a national cooperative study. Circulation 1973;47:Suppl II:II-1-II-108.
14. Monreal M, Ruiz J, Salvador R, Morera J, Arias A. Recurrent pulmonary embolism: a prospective study. Chest 1989;95:976-9.
15. Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993;341:507-11.
16. Stein PD, Hull RD, Raskob G. Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism: consideration of noninvasive management. Ann Intern Med 1994;121:313-7.
17. Levine M, Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:677-81.
18. Koopman MMW, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996;334:682-7.